Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ChemExpress is a China-based pharmaceutical services company that provides integrated CRO and CDMO offerings, together with life science reagents, to global pharma and biotech customers. The company focuses on small molecules and has expanded into biologics and newer modalities including bioconjugates such as ADCs/PDCs/RDCs, peptides, and oligonucleotides. Its service scope covers research reagents and building blocks, process development, analytical and quality services, API and intermediate manufacturing, drug product manufacturing, and regulatory CMC support. ChemExpress positions itself as a one-stop partner across the value chain from starting materials and intermediates through APIs and finished dosage forms. It is a publicly traded company in China and serves thousands of partners globally from a base of multiple R&D and manufacturing sites.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai HaoyuanChemexpress.